CoDa Therapeutics' Series B Round

CoDa Therapeutics raised a round of funding on April 18, 2011.

CoDa Therapeutics is a clinical stage biotechnology company focused on developing targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The compan…

Articles about CoDa Therapeutics' Series B Round: